Aubra EQ
Aubra EQ® (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.1 mg/0.02 mg Rx only Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs) such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
Approved
Approval ID
61207a91-8b3c-4231-b98f-3cb9f4a4be09
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 1, 2023
Manufacturers
FDA
Afaxys Pharma, LLC
DUNS: 080508656
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levonorgestrel and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50102-220
Application NumberANDA206886
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateSeptember 1, 2023
FDA Product Classification